Common use

Exelon contains rivastigmine tartrate, a selective and reversible cholinesterase inhibitor that works primarily in the brain to enhance cognitive function in patients with dementia. As a dual inhibitor of both acetylcholinesterase and butyrylcholinesterase in the cerebral cortex and hippocampus, this Alzheimer treatment medication increases the availability of acetylcholine — a vital neurotransmitter essential for the processes of memory, learning, thinking, and reasoning. In patients with dementia, acetylcholine levels are characteristically depleted, contributing to progressive memory loss and declining cognitive function. Exelon is approved for the treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease dementia (Parkinson dementia), making it one of the most versatile cholinesterase inhibitors available. Clinical studies have demonstrated that rivastigmine improves key parameters of cognitive function, enhances the ability to perform activities of daily living, and reduces the overall severity of Alzheimer's disease symptoms. Many caregivers and patients choose to buy Exelon online for its established efficacy and dual-indication coverage. Exelon generic versions containing the same rivastigmine active ingredient provide an equally effective and more affordable option for long-term dementia medication therapy, helping families manage the significant costs associated with ongoing Alzheimer treatment.



Dosage and direction

The recommended initial dose of Exelon is 1.5 mg taken twice daily (morning and evening), with doses separated by approximately twelve hours. It is best to take rivastigmine with food to reduce the likelihood of gastrointestinal side effects. If the starting dose is well tolerated after a minimum of two weeks of treatment, the dose may be gradually increased to 3 mg twice daily. Further dose titration is possible in increments of 1.5 mg per dose, progressing to 4.5 mg twice daily and ultimately to the maximum recommended dose of 6 mg twice daily, based on individual tolerability and clinical response. Each dose increase should be made at intervals of at least two weeks. This gradual escalation approach is essential for minimizing adverse effects while optimizing the cognitive function benefits of this cholinesterase inhibitor. If treatment is interrupted for more than three days, it should be restarted at the lowest dose (1.5 mg twice daily) and re-titrated to reduce the risk of severe nausea and vomiting. Your doctor will determine the optimal maintenance dose for your specific dementia medication needs.



Precautions

Special caution is required when prescribing Exelon to patients with sick sinus syndrome or other cardiac conduction disorders, severe cardiac arrhythmias, active or history of gastrointestinal ulcers (as cholinesterase inhibitors may increase gastric acid secretion), chronic obstructive pulmonary disease or asthma, urinary tract obstruction, and a history of seizures or convulsions. Patients with low body weight (particularly those under 50 kg) may experience more adverse effects and may require careful dose monitoring throughout their Alzheimer treatment. Rivastigmine may cause dizziness, drowsiness, and syncope, which can increase the risk of falls — an important consideration for elderly patients with memory loss and cognitive impairment. Caregivers should monitor patients closely during dose titration periods and report any significant changes in behavior, appetite, or weight to the treating physician. Adequate hydration should be maintained, particularly if the patient experiences vomiting or diarrhea during treatment with this dementia medication. Regular medical follow-up is essential to assess ongoing cognitive function and adjust the treatment plan as needed.



Contraindications

Exelon is contraindicated in patients with known hypersensitivity to rivastigmine, other carbamate derivatives, or any of the excipients in the formulation. Patients who have previously experienced application-site reactions suggestive of allergic contact dermatitis with rivastigmine transdermal patches should not use any form of this cholinesterase inhibitor. Breastfeeding should be discontinued during treatment with this dementia medication, as rivastigmine may be excreted in breast milk and could affect the nursing infant. Women of childbearing age should discuss the potential risks and benefits of Alzheimer treatment with their doctor, and effective contraception should be used if treatment is necessary. If you have severe hepatic impairment, consult your physician before attempting to buy rivastigmine, as dose adjustments may be required.



Possible side effect

The most frequently reported side effects during Exelon therapy are primarily gastrointestinal in nature and include nausea (the most common adverse reaction), stomach pain, vomiting, loss of appetite, and anorexia. These effects are typically dose-related and most pronounced during the titration phase of this Alzheimer treatment. Additional reported adverse reactions include abdominal pain, diarrhea, headache, dizziness, confusion, agitation, extreme anxiety or fear, fatigue, weakness, and tremor. More serious side effects requiring immediate medical attention include black, bloody, or tarry stools, coughing up blood or vomit that resembles coffee grounds (signs of gastrointestinal bleeding), feeling light-headed or experiencing fainting episodes, chest pain, significant weight loss, painful or burning urination, and signs of dehydration. Bradycardia (slow heart rate) may occur due to the cholinergic mechanism of action of this cholinesterase inhibitor. In rare cases, patients may experience severe skin reactions, pancreatitis, or worsening of Parkinson dementia symptoms. Report any new or worsening symptoms to your healthcare provider promptly, as dose adjustment or discontinuation of the dementia medication may be necessary.



Drug interaction

Exelon may decrease the activity of anticholinergic drugs, potentially reducing their therapeutic effectiveness. Conversely, rivastigmine may enhance the activity of other cholinomimetic agents, including muscle relaxants of the succinylcholine type used during anesthesia — inform your anesthesiologist that you are taking this cholinesterase inhibitor before any surgical procedure. Beta-blockers and other bradycardia-inducing medications may have additive effects on heart rate when combined with this Alzheimer treatment. Inform your doctor about all prescribed medications, over-the-counter drugs, herbal products, and supplements you are currently taking, and pay particular attention to drugs with anticholinergic properties such as atropine (Donnatal and others), clidinium (Quarzan), belladonna, dicyclomine (Bentyl), glycopyrrolate (Robinul), mepenzolate (Cantil), methscopolamine (Pamine), methantheline (Provocholine), propantheline (Pro-Banthine), hyoscyamine (Anaspaz, Cystospaz, Levsin, and others), or scopolamine (Transderm-Scop). Using these medications concurrently with rivastigmine may reduce the cognitive function benefits of your dementia medication.



Missed dose

If you forgot to take your dose of Exelon at the scheduled time, take it as soon as you remember, preferably with food. However, do not take the missed dose if it is nearly time for your next scheduled dose — simply skip it and continue with your regular dosing routine. Never double your dose to compensate for a missed one. Taking your doses at approximately the same times each day helps prevent missed doses and maintains consistent levels of this cholinesterase inhibitor in your system. If you miss several consecutive doses (more than three days), do not restart at your current dose — contact your doctor, as you may need to re-titrate from the lowest dose to avoid severe gastrointestinal side effects and ensure safe continuation of your Alzheimer treatment.



Overdose

Rivastigmine overdose may produce a range of symptoms consistent with excessive cholinergic stimulation. Contact your doctor or emergency services immediately if you experience severe nausea, profuse vomiting, blurred vision, fainting or syncope, feeling light-headed, excessive drooling or salivation, muscle weakness, excessive sweating, slow or irregular heartbeat (bradycardia), shallow or labored breathing, seizures, or convulsions. Overdose of this cholinesterase inhibitor can be serious and potentially fatal if not treated promptly. Atropine sulfate may be used as an antidote in severe cases. Supportive care including monitoring of vital signs and respiratory support should be provided as needed.



Storage

Store Exelon at room temperature between 20-25 C (68-77 F) in a dry location away from excessive moisture, direct heat, and sunlight. Keep the medication in its original container with the lid tightly closed. Do not store in a bathroom or other humid environment. Keep all dementia medications securely out of reach of patients with cognitive impairment who may inadvertently take additional doses, as well as away from children and pets. Dispose of expired rivastigmine tablets according to local pharmaceutical waste guidelines.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. The content is intended for educational purposes and should not replace professional medical advice. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.